The global n-formyl peptide receptor market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The formyl peptide receptors (FPRs) are G protein-coupled receptors. They transduce chemotactic signals in phagocytes and mediate host-defence as well as inflammatory responses which include cell adhesion, directed migration, granule release and superoxide production. Additionally, N-Formyl peptides are potent immunocyte activators. Once released in the circulation, they induce modulation of vascular tone by cellular mechanisms. The major factor driving the growth of the market include the rising prevalence of diabetes across the globe. 

According to the International Diabetes Federation (IDF), in 2021, approximately 537 million adults aged 20-79 years has diabetes globally with 3 in 4 adults with diabetes living in low- and middle-income countries with a mortality rate of 6.7 million people globally. Additionally, the total number of people living with diabetes is anticipated to rise to 643 million by 2030 and 783 million by 2045. Moreover, almost 1 in 2 (240 million) adults living with diabetes are undiagnosed. Hence, the increasing prevalence of diabetes is driving the demand for N-formyl peptide receptor’s as genetic or pharmacological inhibition which leads to increased insulin levels and improved glucose tolerance which in turn is driving the growth of the market.

Moreover, based on type, the market is segmented into FPR, FPR2 and FPR3. FPR2 is expected to hold a prominent share in the market owing to its rising application in the treatment of diseases such as cancer, diabetes, among others. They regulate cell function by binding any one of a wide variety of ligands which include N-Formylmethionine-containing oligopeptides such as N-Formylmethionine-leucyl-phenylalanine (FMLP). Some major players in the market include Bristol-Myers Squibb Co., and Merck KGaA, among others. 

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Type

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Bristol-Myers Squibb Co., and Merck KGaA, among others. 

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How players are addressing challenges to sustain growth?

• Where is the investment opportunity?

Global N-Formyl Peptide Receptor Market Report by Segment

By Type

• FPR1

• FPR2

• FPR3

By Application

• Inflammation

• Diabetes

• Allergies

• Brain Ischemia

• Metastatic Cancer

• Others

Global N-Formyl Peptide Receptor Market Report by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa